公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2008 | Association of Insulin Resistance with Alanine Aminotransferase Activity in Patients with Nonalcoholic Fatty Liver Disease | Wang C.-C.; Wu W.-W.; Hsu C.-S.; Wang P.-C.; Lin H.H.; JIA-HORNG KAO | Tzu Chi Medical Journal | 5 | 0 | |
2009 | Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection | Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; Wang C.-C.; CHI-LING CHEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | American Journal of Gastroenterology | 37 | 34 | |
2010 | Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection | Hsu C.-S.; CHEN-HUA LIU ; CHUN-JEN LIU ; SHIH-JER HSU ; CHI-LING CHEN ; HWANG, JUEY-JEN ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 30 | 30 | |
2007 | Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma | Lin C.-L.; CHEN-HUA LIU ; Chen W.; Huang W.-L.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 78 | 74 | |
2016 | Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy | Hsu C.-S.; SHIH-JER HSU ; Liu W.-L.; DING-SHINN CHEN ; JIA-HORNG KAO | Scientific Reports | 12 | 10 | |
2020 | The association of vitamin D with hepatitis B virus replication: Bystander rather than offender | Wang C.-C.; Tzeng I.-S.; Su W.-C.; Li C.-H.; Lin H.H.; Yang C.-C.; JIA-HORNG KAO | Journal of the Formosan Medical Association | 8 | 5 | |
2015 | Asunaprevir-containing regimens for the treatment of hepatitis C virus infection | Yang S.-S.; JIA-HORNG KAO | Expert Review of Gastroenterology and Hepatology | 6 | 5 | |
2010 | Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: A ten-year observation | ZEI-SHUNG HUANG ; TIEN-SHANG HUANG ; TZY-HAW WU ; MING-FONG CHEN ; Hsu C.-S.; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 42 | 40 | |
2003 | Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Gastroenterology | 491 | 437 | |
2007 | Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: A comparison with chronic carriers | Tong M.J.; Blatt L.M.; JIA-HORNG KAO ; Cheng J.T.; Corey W.G. | Liver International | 82 | 75 | |
2005 | Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B | Lin C.-L.; Liao L.-Y.; Wang C.-S.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Liver International | 72 | 64 | |
2014 | Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients | Wang C.-C.; TAI-CHUNG TSENG ; Wang P.-C.; Lin H.H.; JIA-HORNG KAO | Journal of the Formosan Medical Association | 10 | 10 | |
2020 | Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy | TAI-CHUNG TSENG ; Peng C.-Y; Hsu Y.-C; TUNG-HUNG SU ; Wang C.-C; CHUN-JEN LIU ; HUNG-CHIH YANG ; Yang W.-T; Lin C.-H; Yu M.-L; Lai H.-C; Tanaka Y; Nguyen M.H; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Liver Cancer | 17 | 13 | |
2017 | Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naïve patients with chronic hepatitis B | Wei L.; JIA-HORNG KAO | Current Medical Research and Opinion | 14 | 12 | |
1997 | Benign recurrent intrahepatic cholestasis | CHUN-JEN LIU ; JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; TSUI-LIEN MAO ; Wang T.-H.; DING-SHINN CHEN | Journal of the Formosan Medical Association | 1 | 0 | |
2013 | Biphasic pattern of depression and its predictors during pegylated interferon-based therapy in chronic hepatitis B and C patients | Huang Y.-W.; Hu J.-T.; Hu F.-C.; Chang C.-J.; Chang H.-Y.; JIA-HORNG KAO ; Yang S.-S.; DING-SHINN CHEN | Antiviral Therapy | 8 | 8 | |
1997 | Blood-bank screening for hepatitis G [14] | JIA-HORNG KAO ; PEI-JER CHEN ; JIN-TOWN WANG ; Lai M.-Y.; DING-SHINN CHEN | Lancet | 7 | 5 | |
2018 | Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan | Hsieh M.-H.; Yeh M.-L.; TUNG-HUNG SU ; Liu T.-W.; Huang C.-F.; Huang C.-I.; Wang S.-C.; Huang J.-F.; Dai C.-Y.; JIA-HORNG KAO ; Chuang W.-L.; PEI-JER CHEN ; CHUN-JEN LIU ; Yu M.-L. | Journal of the Formosan Medical Association | 5 | 4 | |
2009 | Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease | Hsu C.-S.; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 0 | 0 | |
1998 | Brief communication: Efficacy of ribavirin plus interferon α on viraemia of GB virus-C/hepatitis G virus: Comparison with interferon α alone | JIA-HORNG KAO ; Lai M.-Y.; Chen W.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Gastroenterology and Hepatology (Australia) | 10 | 10 |